<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0074027-Fried1">
 <label>4</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Fried</surname>
   <given-names>MW</given-names>
  </name>, 
  <name>
   <surname>Shiffman</surname>
   <given-names>ML</given-names>
  </name>, 
  <name>
   <surname>Reddy</surname>
   <given-names>KR</given-names>
  </name>, 
  <name>
   <surname>Smith</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>Marinos</surname>
   <given-names>G</given-names>
  </name>, 
  <etal>et al</etal> (
  <year>2002</year>) 
  <article-title>Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection</article-title>. 
  <source>N Engl J Med</source>
  <volume>347</volume>: 
  <fpage>975</fpage>â€“
  <lpage>982</lpage>
  <comment>doi:;
   <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa020047347/13/975" xmlns:xlink="http://www.w3.org/1999/xlink">10.1056/NEJMoa020047;347/13/975</ext-link>
  </comment>
  <pub-id pub-id-type="pmid">12324553</pub-id>
 </mixed-citation>
</ref>
